We have isolated 165 Caenorhabditis elegans mutants, representing 21 Synaptic transmission is a major mechanism for intercellular communication in the nervous system. Many of the events that mediate synaptic transmission occur presynaptically and center on the synaptic vesicle cycle. The major steps of the synaptic vesicle cycle were described 20-40 years ago by investigators using electrophysiology and electron microscopy (reviewed in refs. 1-3). In brief, neurons produce specialized vesicles that are transported down axons to synaptic sites, where they are filled with neurotransmitter and stored in clusters. A small fraction of the vesicles become docked at active zones on the presynaptic membrane. The arrival of an electrical signal at the synapse induces the opening of voltage-gated calcium channels, and the resulting influx of calcium leads to the fusion of some of the docked synaptic vesicles with the plasma membrane and the release of neurotransmitter into the synaptic cleft. Transmission of the chemical signal is completed when the neurotransmitter binds postsynaptic receptors. The cycle continues in the presynapse with the docking of additional vesicles and the local recycling of fused vesicle membrane by endocytosis. Over the past 15 years, a molecular description of the synaptic vesicle cycle has begun to emerge. Biochemical and molecular studies have been important for the identification and analysis of many presynaptic proteins (reviewed in refs. 4-6) and have illuminated the roles of some of these proteins in the synaptic vesicle cycle.Classical genetic approaches using invertebrates have complemented biochemical studies by identifying additional presynaptic components and by allowing assessment of the function and importance of individual proteins (7)(8)(9)(10)(11)(12) While it has been known for some time that certain C. elegans uncoordinated (Unc) mutants are resistant to AChE inhibitors (13-17), the use of genetic screens to select for Ric mutants directly has thus far resulted in the isolation of mutations in only 6 genes (13,18 4These studies were begun while A

The recycling of synaptic vesicles requires the recovery of vesicle proteins and membrane. Members of the stonin protein family (Drosophila Stoned B, mammalian stonin 2) have been shown to link the synaptic vesicle protein synaptotagmin to the endocytic machinery. Here we characterize the unc-41 gene, which encodes the stonin ortholog in the nematode Caenorhabditis elegans. Transgenic expression of Drosophila stonedB rescues unc-41 mutant phenotypes, demonstrating that UNC-41 is a bona fide member of the stonin family. In unc-41 mutants, synaptotagmin is present in axons, but is mislocalized and diffuse. In contrast, UNC-41 is localized normally in synaptotagmin mutants, demonstrating a unidirectional relationship for localization. The phenotype of snt-1 unc-41 double mutants is stronger than snt-1 mutants, suggesting that UNC-41 may have additional, synaptotagmin-independent functions. We also show that unc-41 mutants have defects in synaptic vesicle membrane endocytosis, including a ∼50% reduction of vesicles in both acetylcholine and GABA motor neurons. These endocytic defects are similar to those observed in apm-2 mutants, which lack the µ2 subunit of the AP2 adaptor complex. However, no further reduction in synaptic vesicles was observed in unc-41 apm-2 double mutants, suggesting that UNC-41 acts in the same endocytic pathway as µ2 adaptin.

We have reconstituted specific RNA polymerase I transcription from three partially purified chromatographic fractions (termed A, B, and C). Here, we present the chromatographic scheme and the initial biochemical characterization of these fractions. The A fraction contained the RNA polymerase I transcription factor(s), which was necessary and sufficient to form stable preinitiation complexes at the promoter. Of the three fractions, only fraction A contained a significant amount of the TATA binding factor. The B fraction contributed RNA polymerase I, and it contained an essential RNA polymerase I transcription factor that was specifically inactivated in response to a significant decrease in growth rate. The function of the C fraction remains unclear. This reconstituted transcription system provides a starting point for the biochemical dissection of the yeast RNA polymerase I transcription complex, thus allowing in vitro experiments designed to elucidate the molecular mechanisms controlling rRNA synthesis.

The cho-1 gene in Caenorhabditis elegans encodes a high-affinity plasma-membrane choline transporter believed to be rate limiting for acetylcholine (ACh) synthesis in cholinergic nerve terminals. We found that CHO-1 is expressed in most, but not all cholinergic neurons in C. elegans. cho-1 null mutants are viable and exhibit mild deficits in cholinergic behavior; they are slightly resistant to the acetylcholinesterase inhibitor aldicarb, and they exhibit reduced swimming rates in liquid. cho-1 mutants also fail to sustain swimming behavior; over a 33-min time course, cho-1 mutants slow down or stop swimming, whereas wildtype animals sustain the initial rate of swimming over the duration of the experiment. A functional CHO-1TGFP fusion protein rescues these cho-1 mutant phenotypes and is enriched at cholinergic synapses. Although cho-1 mutants clearly exhibit defects in cholinergic behaviors, the loss of cho-1 function has surprisingly mild effects on cholinergic neurotransmission. However, reducing endogenous choline synthesis strongly enhances the phenotype of cho-1 mutants, giving rise to a synthetic uncoordinated phenotype. Our results indicate that both choline transport and de novo synthesis provide choline for ACh synthesis in C. elegans cholinergic neurons.

Synaptotagmin 1, encoded by the snt-1 gene in C. elegans, is a major synaptic vesicle protein containing two Ca 2+ -binding (C2) domains. Alternative splicing gives rise to two synaptotagmin 1 isoforms, designated SNT-1A and SNT-1B, which differ in amino acid sequence in the third, fourth, and fifth β-strands of the second C2 domain (C2B). We report here that expression of either SNT-1 isoform under control of a strong pan-neural promoter fully rescues the snt-1 null phenotype. Furthermore, C-terminal fusions of either isoform with GFP are trafficked properly to synapses, and are fully functional, unlike synaptotagmin 1::GFP fusions in mice. Analysis of isoform expression with genomic GFP reporter constructs revealed that the SNT-1A and -1B isoforms are differentially expressed and localized in the C. elegans nervous system. We also report molecular, behavioral, and immunocytochemical analyses of twenty snt-1 mutations. One of these mutations, md259, specifically disrupts expression of the SNT-1A isoform and has defects in a subset of synaptotagmin 1-mediated behaviors. A second mutation, md220, is an in-frame 9-bp deletion that removes a conserved tri-peptide sequence (VIL) in the second β-strand of the C2B domain and disrupts the proper intracellular trafficking of synaptotagmin. Site-directed mutagenesis of a functional SNT-1::GFP fusion protein was used to examine the potential role of the VIL sequence in synaptotagmin trafficking. Although our results suggest the VIL sequence is most likely not a specific targeting motif, the use of SNT-1::GFP fusions has great potential for investigating synaptotagmin trafficking and localization.